Our latest whitepaper will help you to master the key strategies in a successful transfer and scale-up for your pharmaceutical Rx and OTC products.
Growth in the demand for outsourced prescription drug production is accelerating – largely due to an evolving set of business and financial drivers specific to pharmaceutical manufacturing operations.
A primary priority for pharmaceutical companies is the necessity of finding CDMO partners with the specific technical capabilities to transfer their formulations and products into production and then wield their commercial capacity to scale products as quickly and cost effectively as possible.
Every tech transfer operation is unique. If executed well, both partners win - time, cost, product quality and performance risk are greatly reduced.
Bora Pharmaceuticals is a premier international CGMP CDMO specializing in complex oral solid dosage (tablet & capsules), liquids (solutions, suspensions, & nasal sprays) and semi-solids (creams & gels) pharmaceutical Rx and OTC products for late-phase Clinical through Commercial manufacturing and packaging.